AKT1 and cancer: Studies have shown that the PI3K/Akt pathway is able to enhance Gli1 activity through phosphorylation or stabilization mechanisms, often creating a reciprocal amplification loop, fueling not only the growth of cancer cells but also their ability to avoid therapies.